SEC Form 4 research
| Issuer | Ultragenyx Pharmaceutical Inc. |
|---|---|
| Tickers | RARE |
| Reporting owners | 31 |
| Officers and directors | 18 |
| Last public filing | 2026-09-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-15 | 2026-09-15 | Huizenga Theodore Alan | S | 1,283 | $13.57 | Not reported |
| 2026-09-08 | 2026-09-03 | Huizenga Theodore Alan | S | 161 | $13.99 | Not reported |
| 2026-08-04 | 2026-08-03 | Parschauer Karah Herdman | S | 1,900 | $24.92 | Not reported |
| 2026-08-04 | 2026-08-03 | Horn Howard | S | 4,696 | $24.92 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.